Pettit, MD, and participants discussed second-line considerations in high-risk polycythemia after hydroxyurea failure.
Neo7Bioscience Announces Precision Signal Interception for Pancreatic Cancer Treatment Beyond Conventional RAS Pathway Suppression ...
A large-scale clinical trial has shown that even long-term consumption of DHA—an omega-3 fatty acid found in abundance in ...
Researchers are investigating the potential of CRISPR in relation to Down syndrome.
Deep learning variant calling has transformed genomic accuracy. Discover how DeepVariant works, outperforms classical tools, ...
Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for ...
The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth $8.37 ...
Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Morning Overview on MSN
Mutations behind blood cancers may help ignite Alzheimer’s in the brain
Mutations that accumulate in blood cells with age and raise the risk of leukemia and lymphoma can also colonize the brain’s ...
KRAS G12C occurs in ~3%–4% of CRC, translating to a sizable metastatic population with limited options and strong rationale for KRAS G12C inhibition strategies. Dual KRAS–EGFR blockade leverages ...
Morning Overview on MSN
An Alzheimer’s risk gene scrambles brain circuits years before any memory slips
Researchers at the Gladstone Institutes have identified a specific protein, Nell2, that causes neurons in the hippocampus to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results